Skip to main content

Advertisement

Open Peer Review Reports for: Cefuroxime, levofloxacin, esomeprazole, and bismuth as first-line therapy for eradicating Helicobacter pylori in patients allergic to penicillin

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
14 Dec 2018 Submitted Original manuscript
26 Jan 2019 Author responded Author comments - Zhiqiang Song
Resubmission - Version 2
26 Jan 2019 Submitted Manuscript version 2
13 Feb 2019 Reviewed Reviewer Report - Arjuna De Silva
13 Feb 2019 Reviewed Reviewer Report - Irene Coati
23 Feb 2019 Author responded Author comments - Zhiqiang Song
Resubmission - Version 3
23 Feb 2019 Submitted Manuscript version 3
20 Mar 2019 Reviewed Reviewer Report - Arjuna De Silva
5 Apr 2019 Reviewed Reviewer Report - Hideki Mori
17 Apr 2019 Reviewed Reviewer Report - Chao-Hung Kuo
2 May 2019 Author responded Author comments - Zhiqiang Song
Resubmission - Version 4
2 May 2019 Submitted Manuscript version 4
8 May 2019 Reviewed Reviewer Report - Hideki Mori
24 May 2019 Reviewed Reviewer Report - Chao-Hung Kuo
1 Jun 2019 Author responded Author comments - Zhiqiang Song
Resubmission - Version 5
1 Jun 2019 Submitted Manuscript version 5
2 Jul 2019 Reviewed Reviewer Report - Chao-Hung Kuo
3 Jul 2019 Author responded Author comments - Zhiqiang Song
Resubmission - Version 6
3 Jul 2019 Submitted Manuscript version 6
16 Jul 2019 Reviewed Reviewer Report - Chao-Hung Kuo
Resubmission - Version 7
Submitted Manuscript version 7
Publishing
21 Jul 2019 Editorially accepted
25 Jul 2019 Article published 10.1186/s12876-019-1056-3

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement